Information about Primary Pulmonary Hypertension and other forms of Severe
Pulmonary Hypertension
PPH NEWS is an education-based resource site that provides information on the health issues surrounding Primary Pulmonary Hypertension (PPH), including what it is, the symptoms, diagnoses, and treatment options.
This website also provides resource to learn more about your legal rights and remedies if you or someone you know has developed PPH due to the use of diet drugs such as Fen Phen.
Get a FREE Evaluation
Select your state to
contact a PPH Lawyer
Pulmonary Hypertension is a very serious lung and heart disorder related to the blood vessels in the lungs. When a person has Pulmonary Hypertension these blood vessels constrict, increasing pressure in the pulmonary artery (connecting the heart to the lungs) and creating a life-threatening situation. Pulmonary Hypertension causes the tiny blood vessels in the lungs to change and close off, preventing blood from flowing freely. Victims of Pulmonary Hypertension suffer additional stress to the right ventricle of the heart, which has to work harder and harder to circulate enough blood through the lungs.
Symptoms of Pulmonary Hypertension include shortness of breath (also called dyspnea), which can come about even with little or no physical exertion. Pulmonary Hypertension also causes fatigue, chest pain, dizziness and fainting spells. Most persons diagnosed with Pulmonary Hypertension die within three years of diagnosis, although new treatments and early diagnosis are extending that time somewhat. Currently, Pulmonary Hypertension victims may be able to survive for ten years or more following their diagnosis.
There are two types of Pulmonary Hypertension: Primary and Secondary. Both forms of this disorder are similar in all but causes: Secondary Pulmonary Hypertension can be attributed to a specific cause, while Primary Pulmonary Hypertension cannot be linked to a specific cause. Ironically, when the disease is classified as Primary Pulmonary Hypertension, it is often connection to diet drug use, although the causal relationship has not been clearly established, since doctors do not yet fully understand the mechanics of that link.
Pulmonary Hypertension is a rare disease, only occurring in around two persons per million annually. Because it is so rare and the symptoms are so common to other diseases, Pulmonary Hypertension is often diagnosed only in the very late stages. In fact, the average length of time from the onset of symptoms to a Pulmonary Hypertension diagnosis is two years. This affects treatment options, increasing the chances of mortality.
Treating Pulmonary Hypertension usually focuses on extending the life span of the patient. There are few drugs approved for the treatment of Pulmonary Hypertension, and they are extremely expensive. The most effective way to treat Pulmonary Hypertension is through a single or double lung transplant, but these procedures are also very expensive, and the wait for a lung transplant is too long for many Pulmonary Hypertension victims. In rare cases, a heart transplant may also be required, but the heart strain is generally reversed naturally following a lung transplant.
Because Primary Pulmonary Hypertension has been linked to the use of diet drugs such as Fen-Phen, victims may be entitled to compensation from the drug manufacturers. Primary Pulmonary Hypertension was known to have developed in weight loss pill users in Europe, yet American companies continued to market diet pills as safe weight loss options. Primary Pulmonary Hypertension victims are able to bring claims for compensation, including the cost of medical treatment, lost wages, and pain and suffering. Awards in the millions of dollars for Primary Pulmonary Hypertension sufferers (or their surviving loved ones) are not uncommon. To learn more about Primary Pulmonary Hypertension and your legal rights, contact an attorney who has experience in working with victims of diet drugs.
Contact a PPH Lawyer by clicking on your state below:
Problems Associated
with Fen Phen
Patients suffering from Primary Pulmonary Hypertension (PPH) caused by Fen-Phen, Pondimin or Redux are not included in the Nationwide Class Action Settlement Agreement with American Home Products. PPH patients must file independent lawsuits to make legal claims. To learn your legal rights, please contact us and speak with a PPH Lawyer for lawsuit information!